Corbotics has successfully closed a new investment round, backed largely by our existing shareholders.

The continued commitment of our shareholders is a strong signal of confidence in our team, our technology, and our goal to make cardiac ultrasound more accessible.

Combined with the grants we recently secured, the €2.5 million EIC-Accelerator grant and the Innovation Credit (Innovatiekrediet) from RVO, this round provides Corbotics with a financial runway until Q1 2028.

This funding allows us to focus fully on what matters: bringing our autonomous cardiac echo robot to the market for the betterment of medical professionals and patients. By getting our product on the market, we believe we can scale up cardiac ultrasound exams and improve early detection of cardiovascular diseases, giving patients on-time access to treatment.

Visit our product page to see our autonomous cardiac echo robot in action.